Consensus STERIS plc

Equities

STE

IE00BFY8C754

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
222.9 USD -0.15% Intraday chart for STERIS plc -2.74% +1.38%

Evolution of the average Target Price on STERIS plc

Price target over the last 5 years

History of analyst recommendation changes

7f09c31b036243.DcSU2vw1FvaXfTitya1mHGV3mQ5tXMrUcdCt7W45FeU.YenhnqxqXqfVL17Zj_cHSRIVzlYGFIyRIrWarzhcUZ1KlNadrE9Vk-4IcQ~6899298c8c5c8127c38aa2951442880a
Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing MT
Steris Insider Sold Shares Worth $475,300, According to a Recent SEC Filing MT
Steris Insider Sold Shares Worth $707,850, According to a Recent SEC Filing MT
Steris Insider Sold Shares Worth $476,093, According to a Recent SEC Filing MT
Wolfe Research Adjusts Price Target on STERIS to $240 From $235 MT
Piper Sandler Adjusts Price Target on STERIS to $225 From $220 MT
KeyBanc Adjusts Price Target on STERIS to $255 From $253 MT
Wolfe Research Adjusts STERIS Price Target to $235 From $245 MT
Morgan Stanley Cuts Price Target on STERIS to $215 From $225, Keeps Equalweight Rating MT
ANALYST RECOMMENDATIONS : Biogen, Conocophillips, Kellanova, Take Two, Tesla... Our Logo
Piper Sandler Adjusts Price Target on STERIS to $215 From $220, Maintains Neutral Rating MT
All hail the resilience of the US economy Our Logo
ANALYST RECOMMENDATIONS : Adobe, Live Nation, Meta, Snap, Wpp... Our Logo
JMP Securities Adjusts STERIS' Price Target to $265 From $240, Keeps Market Outperform Rating MT
Morgan Stanley Adjusts Price Target on STERIS to $225 From $206, Maintains Equalweight Rating MT
KeyBanc Adjusts Price Target on STERIS to $258 From $254, Maintains Overweight Rating MT
KeyBanc Lifts Price Target on STERIS to $254 From $235, Says Initial Guidance 'Likely Conservative,' Keeps Overweight Rating MT
Stephens Adjusts STERIS' Price Target to $250 From $240, Keeps Overweight Rating MT
Morgan Stanley Initiates Coverage on STERIS With Equal Weight Rating, $206 Price Target MT
Piper Sandler Adjusts Price Target on STERIS to $200 From $197, Keeps Neutral Rating MT
Keybanc Adjusts Price Target on STERIS to $235 From $210, Keeps Overweight Rating MT
Piper Sandler Downgrades STERIS to Neutral From Overweight, Adjusts Price Target to $197 From $215 MT
Piper Sandler Cuts Price Target on STERIS to $215 From $235, Maintains Overweight Rating MT
KeyBanc Adjusts STERIS' Price Target to $210 From $240, Keeps Overweight Rating MT
Needham Downgrades STERIS to Hold From Buy on Capital Equipment Exposure, Potential Ethylene Oxide Liabilities; $237 Price Target Removed MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
222.9 USD
Average target price
243.5 USD
Spread / Average Target
+9.25%
High Price Target
265 USD
Spread / Highest target
+18.90%
Low Price Target
215 USD
Spread / Lowest Target
-3.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering STERIS plc

KeyBanc Capital Markets
Piper Sandler
Wolfe Research
Morgan Stanley
JMP Securities
Stephens Inc.
Needham & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings